CN105793419B - 修饰的kz144内溶素序列 - Google Patents

修饰的kz144内溶素序列 Download PDF

Info

Publication number
CN105793419B
CN105793419B CN201480062330.1A CN201480062330A CN105793419B CN 105793419 B CN105793419 B CN 105793419B CN 201480062330 A CN201480062330 A CN 201480062330A CN 105793419 B CN105793419 B CN 105793419B
Authority
CN
China
Prior art keywords
polypeptide
seq
amino acid
sequence
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480062330.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN105793419A (zh
Inventor
S·米勒
R·斯特纳
H·斯图尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lysando AG
Original Assignee
Lysando AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lysando AG filed Critical Lysando AG
Publication of CN105793419A publication Critical patent/CN105793419A/zh
Application granted granted Critical
Publication of CN105793419B publication Critical patent/CN105793419B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201480062330.1A 2013-11-14 2014-11-14 修饰的kz144内溶素序列 Active CN105793419B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2013/073869 2013-11-14
PCT/EP2013/073869 WO2015070911A1 (en) 2013-11-14 2013-11-14 Modified kz144 endolysin sequence
PCT/EP2014/074671 WO2015071436A1 (en) 2013-11-14 2014-11-14 Modified kz144 endolysin sequence

Publications (2)

Publication Number Publication Date
CN105793419A CN105793419A (zh) 2016-07-20
CN105793419B true CN105793419B (zh) 2021-06-01

Family

ID=49582760

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480062330.1A Active CN105793419B (zh) 2013-11-14 2014-11-14 修饰的kz144内溶素序列

Country Status (10)

Country Link
US (1) US10184120B2 (enExample)
JP (1) JP6745720B2 (enExample)
KR (1) KR102302044B1 (enExample)
CN (1) CN105793419B (enExample)
AU (1) AU2014350104B2 (enExample)
BR (1) BR112016011091B1 (enExample)
CA (1) CA2929686C (enExample)
EA (1) EA035959B1 (enExample)
MX (1) MX374403B (enExample)
WO (2) WO2015070911A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018003101A (es) 2015-09-17 2018-12-17 Contrafect Corp Activo de polipeptidos de lisina contra bacterias gram-negativas.
CA3022334A1 (en) * 2016-04-28 2017-11-02 Lysando Ag Antimicrobial agents against salmonella bacteria
WO2017203471A1 (en) * 2016-05-27 2017-11-30 Sasinapas Co., Ltd. Endolysin variant
WO2018100408A1 (en) * 2016-11-30 2018-06-07 Sasinapas Co.,Ltd. Modified peptides
CN110651044A (zh) * 2017-04-03 2020-01-03 萨西那帕斯有限公司 工程化的革兰氏阴性细胞内溶素
JP7515409B2 (ja) * 2018-05-30 2024-07-12 ライサンド アーゲー 新規抗微生物融合タンパク質
CN111304181B (zh) * 2020-02-17 2021-11-23 华东理工大学 一种基因工程改造后的副溶血性弧菌噬菌体裂解酶及其制备方法和应用
KR20250044545A (ko) 2023-09-23 2025-04-01 조배근 사료급이기 청소기

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458452A (zh) * 2009-06-26 2012-05-16 勒芬天主教大学，K.U.勒芬R&D 抗微生物剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289092C (en) * 1987-01-15 1991-09-17 Robert A. Hallewell Thermostable human cu/zn superoxide dismutase muteins
EP0285123A3 (en) 1987-04-03 1989-02-01 Stabra AG A method for complete mutagenesis of nucleic acids
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
JPH08127540A (ja) * 1994-09-09 1996-05-21 Takeda Chem Ind Ltd 抗潰瘍医薬
CN101952424A (zh) * 2007-08-22 2011-01-19 海格罗斯投资有限责任公司 用于人类和动物葡萄球菌感染的新蛋白
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
EP2470648B1 (en) * 2009-08-24 2019-04-10 Katholieke Universiteit Leuven K.U. Leuven R&D New endolysin obpgplys
SG184836A1 (en) * 2010-04-27 2012-11-29 Lysando Ag Method of reducing biofilms
GB201018518D0 (en) * 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (en) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
KR20130142837A (ko) * 2012-06-20 2013-12-30 한국외국어대학교 연구산학협력단 슈도모나스 에루기노사의 박테리오파아지 및 그 용도

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458452A (zh) * 2009-06-26 2012-05-16 勒芬天主教大学，K.U.勒芬R&D 抗微生物剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages _KZ and EL;Yves Briers等;《molecular microbiology》;20070730;全文 *
The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144;Yves Briers等;《biochemical and biophysical research communications》;20090405;全文 *

Also Published As

Publication number Publication date
WO2015070911A1 (en) 2015-05-21
BR112016011091B1 (pt) 2024-02-06
CA2929686A1 (en) 2015-05-21
BR112016011091A2 (pt) 2017-12-05
US10184120B2 (en) 2019-01-22
WO2015071436A1 (en) 2015-05-21
CA2929686C (en) 2023-08-08
JP6745720B2 (ja) 2020-08-26
KR20160085342A (ko) 2016-07-15
US20160281074A1 (en) 2016-09-29
MX374403B (es) 2025-03-06
KR102302044B1 (ko) 2021-09-15
EA035959B1 (ru) 2020-09-07
NZ719338A (en) 2022-03-25
MX2016006277A (es) 2017-01-05
EA201691004A1 (ru) 2017-01-30
JP2016537979A (ja) 2016-12-08
CN105793419A (zh) 2016-07-20
AU2014350104B2 (en) 2020-03-05
AU2014350104A1 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
CN105793419B (zh) 修饰的kz144内溶素序列
JP7515535B2 (ja) 黄色ブドウ球菌に対する新規抗微生物剤
US10167462B2 (en) Modified EL188 endolysin sequence
Wei et al. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli
KR102560651B1 (ko) 엔테로코커스 박테리아에 대한 신규한 항미생물제
KR20200012844A (ko) 조작된 그람-음성 엔도리신
Wang et al. Rapid and efficient production of cecropin A antibacterial peptide in Escherichia coli by fusion with a self-aggregating protein
CN103641901A (zh) 一种抗菌肽
Li et al. Structural Characteristics, Prokaryotic Expression and Activity Analysis of Antimicrobial Peptide ALF Pm10 from Penaeus monodon
EP3068877B1 (en) Modified kz144 endolysin sequence
Cheng et al. Expression and purification of antimicrobial peptide CM4 by Npro fusion technology in E. coli
EP3068878B1 (en) Modified el188 endolysin sequence
HK1228944A1 (en) Modified kz144 endolysin sequence
HK1228944B (en) Modified kz144 endolysin sequence
NZ719338B2 (en) Modified kz144 endolysin sequence
HK40014646B (en) New antimicrobial agents against staphylococcus aureus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant